BRTX vs UBER · rev $401.0K vs P/E 18, rev $52.02B
BioRestorative Therapies Inc (BRTX) versus Uber Technologies Inc (UBER) — a side-by-side from cached financials, not a winner call.
BioRestorative Therapies Inc (BRTX) is a biotechnology company listed on NASDAQ.
Uber Technologies Inc (UBER) is a software - application company listed on NYSE. It is led by Dara Khosrowshahi.
Latest reported BRTX revenue for 2024-12-31 was $401.0K. Net income was -$9.0M. Revenue was up 175.0% from 2023-12-31 to 2024-12-31. BRTX currently screens at market cap $10.2M.
Latest reported UBER revenue for 2025-12-31 was $52.02B. Net income was $10.05B. Revenue was up 18.3% from 2024-12-31 to 2025-12-31. UBER currently screens at market cap $144.34B and trailing P/E 17.6.
BRTX currently screens at market cap $10.2M. UBER currently screens at market cap $144.34B and trailing P/E 17.6.
Not investment advice. Open the BRTX and UBER stock pages for the full models.
Not investment advice.